RenovoRx, Inc . (“RenovoRx” or “the Company”) (Nasdaq: RNXT) , a life-sciences company developing innovative targeted ...
This research 'holds promise for advancing studies on using pig livers to support or even replace human liver function,' says ...
Continuous Local Antibiotic Perfusion: A Novel Technique for the Treatment of Orthopaedic Infections
Orthopedic infections, including fracture-related infection and periprosthetic joint infection (PJI), remain difficult to ...
LOS ALTOS, Calif.--(BUSINESS WIRE)--RenovoRx, Inc. (Nasdaq: RNXT), a biopharmaceutical company focused on the localized treatment of difficult-to-treat solid tumors through its proprietary RenovoRx ...
FUJIFILM Biosciences, a global leader in the innovation and manufacture of cell culture solutions for the Life Science market, today announced the commercial launch of BalanCD HEK293 Perfusion A.
A patient with liver failure remains in stable condition two days after receiving a novel therapy using gene-edited pig liver ...
New Pharmacokinetic (PK) and Pharmacodynamic Data from Sub-Study in Phase III Trial Strengthens Scientific Basis for RenovoRx’s TAMP Therapy Platform as a Targeted Drug-Delivery Approach Data Shows a ...
First commercially available cell culture solution for HEK293 cells and perfusion -– optimized for high cell density (HCD), intensified processes and perfusion cultures Additional capabilities for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results